Challenges

Virutech Systems, Inc. > Challenges

Challenges

Current Tests are Slow and Use Inaccurate Chemical Methods

TMPI has had long-term working relationships with Intel, Northrop Grumann, and Winegard Company all of which make System components. ViruTech is currently assessing its manufacturing needs as it begins to look towards commercial manufacturing of the System.

ViruTech’s Management believes widespread use of the System has the potential to improve public health and our country’s economic recovery.

Anticipated positive impacts of the System include the ability of businesses to rapidly ascertain the presence or absence of the SARS Virus in anyone seeking access to medical facilities, offices, schools, factories, entertainment venues, government facilities, commercial buildings, and
places of worship.

20.4

Covid Cases

290

Covid Deaths

1

Covid Hospitalizations